Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Dennis S. W. Lee, Olga L. Rojas, Jennifer L. Gommerman
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 3, pp. 179-199
Open Access | Times Cited: 462

Showing 1-25 of 462 citing articles:

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis, Mihir Kakara, Mark M. Painter, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 1990-2001
Open Access | Times Cited: 485
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 355
CAR T therapy beyond cancer: the evolution of a living drug
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 238
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 197
Metabolic adaptation of lymphocytes in immunity and disease
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 185
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Marc Charabati, Michael A. Wheeler, Howard L. Weiner, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1309-1327
Open Access | Times Cited: 119
Targeted Immunotherapy for Autoimmune Disease
Seung Min Jung, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 109
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Fredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
JAMA Neurology (2022) Vol. 79, Iss. 11, pp. 1105-1105
Open Access | Times Cited: 105
Xist ribonucleoproteins promote female sex-biased autoimmunity
Diana R. Dou, Yanding Zhao, Julia A. Belk, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 733-749.e16
Open Access | Times Cited: 103
Age-associated B cells in autoimmune diseases
Isobel C. Mouat, Erin J. Goldberg, Marc S. Horwitz
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 101
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets
Bonan Chen, Peiyao Yu, Wai Nok Chan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 90
Neuroinflammation: An astrocyte perspective
Hong‐Gyun Lee, Joon-Hyuk Lee, Lucas E. Flausino, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 721
Open Access | Times Cited: 79
Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice
Kevin M. Nickerson, Shuchi Smita, Kenneth B. Hoehn, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 52
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy
Martin Schulz, David Lévy, Christos J. Petropoulos, et al.
Molecular Therapy (2023) Vol. 31, Iss. 3, pp. 616-630
Open Access | Times Cited: 47
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
Raffaele Iorio
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 84-98
Closed Access | Times Cited: 35
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 32
Chimeric antigen receptor T cell therapy for autoimmune disease
James Chung, Jennifer N. Brudno, Dominic Borie, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 29
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Annals of the Rheumatic Diseases (2024) Vol. 84, Iss. 1, pp. 106-114
Open Access | Times Cited: 27
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment
Nils Erik Gilhus, Henning Andersen, Linda Kahr Andersen, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 5
Open Access | Times Cited: 23
Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases
Jie Wen, Jingwei Zhang, Hao Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet Neurology (2024) Vol. 23, Iss. 6, pp. 615-624
Open Access | Times Cited: 21
Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 19
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Alise Carlson, Moein Amin, Jeffrey A. Cohen
Drugs (2024) Vol. 84, Iss. 3, pp. 285-304
Open Access | Times Cited: 18
Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
Sean J. Pittock, Αναστασία Ζεκερίδου, Brian G. Weinshenker
Nature Reviews Neurology (2021) Vol. 17, Iss. 12, pp. 759-773
Closed Access | Times Cited: 92
Page 1 - Next Page

Scroll to top